AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On August 27, 2025,
(SCHW) traded with a volume of $0.49 billion, a 34.2% decline from the previous day, ranking 168th in market activity. The stock closed down 0.38%, reflecting mixed institutional and analyst sentiment ahead of broader market trends.Recent institutional activity highlighted growing confidence in the stock.
Bank increased its stake by 14.5% in Q1, now holding 359,348 shares valued at $28.1 million. Similarly, CW Advisors LLC boosted its position by 583.1%, acquiring 17,377 additional shares, raising its holdings to $1.6 million. These moves align with a broader trend of institutional investors accumulating , with 84.38% of shares owned by such entities.The company announced a $20 billion share repurchase program on July 24, authorizing buybacks of up to 11.6% of its stock. This initiative underscores management’s belief in the stock’s undervaluation and follows a Q2 earnings report that exceeded expectations, with $1.14 in earnings per share and $5.85 billion in revenue. Analysts have responded positively, with
and raising price targets to $113 and $110, respectively. The stock now carries a "Moderate Buy" consensus rating and an average target of $99.60.Insider transactions showed mixed activity. Nigel J. Murtagh and Paul V. Woolway sold shares in July and August, reducing their holdings by 29% and 20.55%, respectively. However, these sales occurred amid broader institutional accumulation. The company’s dividend policy remains stable, with a $0.27 quarterly payout and a 29.03% payout ratio, reflecting disciplined capital allocation.
Backtest results indicated limited direct relevance to SCHW’s performance. Notable developments included ENGO Eyewear’s product launch, Healthy Extracts’
expansion, and Palantir’s class-action lawsuit. These events, while significant in their respective sectors, did not impact Schwab’s stock directly.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.25 2025

Dec.24 2025

Dec.24 2025

Dec.23 2025

Dec.23 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet